CDKN2A and leukoplakia: The study showed that healthy tissue and healthy regions from patients with leukoplakia have significant differences from leukoplakia and OSCC tissues, as determined using histological and mechanical evaluations by measuring tissue stiffness and the expression levels of p16 and BCL-2, which showed that healthy regions from patients with leukoplakia could be used as a control [64].